Renal mass imaging modalities: does body mass index (BMI) matter?
International Urology and Nephrology · 2024
DOI: 10.1007/s11255-024-03962-5 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Urology and Nephrology, 2024. Verfasst von Young Son und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jefferson Health New Jersey, 18 E Laurel Rd, Stratford, NJ, 08084, USA. youngso@pcom.edu. Hauptthemen laut MEDLINE: Body Mass Index, Kidney Neoplasms, Tomography, X-Ray Computed, Magnetic Resonance Imaging. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Accurate measurement of renal mass size is crucial in the management of renal cancer. With the burdensome cost of imaging yet its need for management, a better understanding of the variability among patients when determining mass size remains of urgent importance. Current guidelines on optimal imaging are limited, especially with respect to body mass index (BMI). The aim of this study is to discern which modalities accurately measure renal mass size and whether BMI influences such accuracy.
Methods
A multi-institutional chart review was performed for adult patients undergoing partial or radical nephrectomy between 2018 and 2021, with 236 patients ultimately included. Patients were categorized by BMI (BMI 1: 18.5–24.9, BMI 2: 25–29.9, BMI 3: 30–34.9, and BMI 4: ≥ 35). The greatest mass lengths were compared between the pathology report and the following: computerized tomography (CT), renal ultrasound, and magnetic resonance imaging (MRI).
Results
The difference between greatest length on CT with contrast and MRI were significantly different when compared to pathologic measurement. BMI groups 3 and 4 were found to have a significant difference in size estimates compared to BMI 2 for CT with contrast. No difference was found between size estimates by BMI group for any other imaging modality.
Conclusion
CT with contrast becomes less accurate at estimating mass size for patients with BMI > 30. While contrast-enhanced CT remains a vital imaging modality for tissue enhancement in the context of unknown renal masses, caution must be used for mass size estimation in the obese population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Jefferson Health New Jersey, 18 E Laurel Rd, Stratford, NJ, 08084, USA. youngso@pcom.edu.
- Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, TX, USA.
- School of Osteopathic Medicine, Rowan University, Stratford, NJ, USA.
- Lake Erie College of Osteopathic Medicine, Erie, PA, USA.
- College of Science and Mathematics, Rowan University, Glassboro, NJ, USA.
- College of Osteopathic Medicine, Nova Southeastern University, Tampa Bay, FL, USA.
Zitieren
APA
Son, Y., Quiring, M. E., Dalton, R. M., Thomas, B., Davidson, N., DeVincentz, D., Payne, C., Parikh, S. H., Fink, B. A., Mueller, T., & Brown, G. (2024). Renal mass imaging modalities: does body mass index (BMI) matter?. International Urology and Nephrology. https://doi.org/10.1007/s11255-024-03962-5
Vancouver
Son Y, Quiring ME, Dalton RM, Thomas B, Davidson N, DeVincentz D, et al. Renal mass imaging modalities: does body mass index (BMI) matter?. International Urology and Nephrology. 2024. doi:10.1007/s11255-024-03962-5
BibTeX
@article{Son2024,
author = {Son, Young and Quiring, Mark E and Dalton, Raeann M and Thomas, Brian and Davidson, Noah and DeVincentz, Dayna and Payne, Collin and Parikh, Sahil H and Fink, Benjamin A and Mueller, Thomas and Brown, Gordon},
title = {Renal mass imaging modalities: does body mass index (BMI) matter?},
journal = {International Urology and Nephrology},
year = {2024},
doi = {10.1007/s11255-024-03962-5}
}
EUVIMED